Chromosomal regions involved in the pathogenesis of osteosarcomas.
about
Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcomaOsteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate TherapiesSGF29 and Sry pathway in hepatocarcinogenesisMYC activation is a hallmark of cancer initiation and maintenanceAmplification and overexpression of COPS3 in osteosarcomas potentially target TP53 for proteasome-mediated degradationAn imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets.Inactivation of MYC reverses tumorigenesis.Evaluation of paediatric osteosarcomas by classic cytogenetic and CGH analyses.Biomarkers in Osteosarcoma.Genetic variation at chromosome 8q24 in osteosarcoma cases and controls.Ladder-like amplification of the type I interferon gene cluster in the human osteosarcoma cell line MG63The novel myxofibrosarcoma cell line MUG-Myx1 expresses a tumourigenic stem-like cell population with high aldehyde dehydrogenase 1 activity.Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcomaThe genetics of osteosarcoma.AMACR amplification and overexpression in primary imatinib-naïve gastrointestinal stromal tumors: a driver of cell proliferation indicating adverse prognosis.The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability.Genes proximal and distal to MYCN are highly expressed in human neuroblastoma as visualized by comparative expressed sequence hybridizationThe transcription factor CREBZF is a novel positive regulator of p53.Myc coordinates transcription and translation to enhance transformation and suppress invasiveness.Array-based comparative genomic hybridization for genomic-wide screening of DNA copy number alterations in aggressive bone tumors.Recurrent RECQL4 imbalance and increased gene expression levels are associated with structural chromosomal instability in sporadic osteosarcomaInfluence of genetic background on tumor karyotypes: evidence for breed-associated cytogenetic aberrations in canine appendicular osteosarcoma.Cause and consequences of genetic and epigenetic alterations in human cancer.Advances in the identification of molecular markers for bone neoplasia.Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?Genetic factors conferring metastasis in osteosarcoma.Establishment of a new human osteosarcoma cell line, UTOS-1: cytogenetic characterization by array comparative genomic hybridization.P53 oncosuppressor influences selection of genomic imbalances in response to ionizing radiations in human osteosarcoma cell line SAOS-2.Long non-coding RNA tumor suppressor candidate 7 functions as a tumor suppressor and inhibits proliferation in osteosarcoma.High frequency ofMYCgene amplification is a common feature of radiation-induced sarcomas. Further results from EORTC STBSG TL 01/01
P2860
Q24801656-6CCF4B53-3B55-4603-835A-B2DAEEF67504Q26782646-6D2453B7-9A50-4584-B9C4-882B3D4DC0D6Q26795760-F3769CE1-97FF-4A55-986C-A5857CAB80DCQ27026026-B5F2121F-D301-4E25-8971-EFB8322D9FF8Q28201673-2DE1B51E-9E07-4AAB-8ABB-CD3EC108DF91Q33692066-AD79A679-C4BF-4235-A4A6-665D11D8559FQ33784668-DDE44049-5E0C-44FF-B306-4FDB17A8A7B3Q33919098-CDB3EFFD-D6CE-4800-A414-196D19440FA9Q33929072-7DD75FEC-ABAF-4C1F-B8F3-3D507B4AED86Q34042362-2E4775EC-BF95-40A9-AA06-0450871F02A0Q34344422-963A17D2-BD0E-4192-B087-51E0E0ED515FQ34449025-98EA9572-C6F6-49D3-8DB9-5468B2BFEBAAQ34593395-C788A368-D0B8-41D3-8EC4-D54DC1CB4E38Q34639086-424C4057-FEE6-42F5-ADC6-8D4DBE8A4835Q34957349-67ADF239-EF44-4568-A250-61433C8D6B07Q36161258-9B4CC156-F051-4BAB-9F27-FBC3C758CA08Q36357428-F86FC059-7411-429B-B17A-4382070AECC0Q36392179-082A2C35-CB66-4679-82CE-12445D625A98Q36393958-C73BF7F0-BB8D-462E-B166-83A0AF1AA2DDQ36621377-C63D6F54-1A08-4080-8935-E6B00B78E4E4Q37109546-D334AA90-D17F-4E00-B215-0DD1A603C642Q37136952-804A0C72-31EB-4148-90C4-0F64F5EE9A49Q37511752-564A8EA7-DF73-434E-B299-45A772FA4D0BQ38089888-67923CAF-181E-49BE-9C91-F147D26FD9F6Q38209599-77589FE0-DBCE-4652-8F2A-3BE192C8B1F9Q38806986-B984273C-2752-495C-990B-5C857FA35644Q39880204-91D2F7B3-5AD7-437B-9B4D-BBA8D9950938Q39956747-9DA09F27-B668-4972-A41C-2EE5A9CD2AACQ52888387-F8D33D08-E1A0-4BAC-98E1-4E6BC4ABC1BBQ57570722-D3C97626-636D-4830-8BBB-EC1DB712A629
P2860
Chromosomal regions involved in the pathogenesis of osteosarcomas.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Chromosomal regions involved in the pathogenesis of osteosarcomas.
@ast
Chromosomal regions involved in the pathogenesis of osteosarcomas.
@en
Chromosomal regions involved in the pathogenesis of osteosarcomas.
@nl
type
label
Chromosomal regions involved in the pathogenesis of osteosarcomas.
@ast
Chromosomal regions involved in the pathogenesis of osteosarcomas.
@en
Chromosomal regions involved in the pathogenesis of osteosarcomas.
@nl
prefLabel
Chromosomal regions involved in the pathogenesis of osteosarcomas.
@ast
Chromosomal regions involved in the pathogenesis of osteosarcomas.
@en
Chromosomal regions involved in the pathogenesis of osteosarcomas.
@nl
P2093
P2860
P4510
P1476
Chromosomal regions involved in the pathogenesis of osteosarcomas
@en
P2093
P2860
P304
P356
10.1002/1098-2264(200007)28:3<329::AID-GCC11>3.0.CO;2-F
P577
2000-07-01T00:00:00Z